You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (560)

Journals (0)

1-10 of 560 results for relapsed/refractory patients

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: The role of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukemia

Free access

Review article

First published 2016-6

The role of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukemia

Jonathan E. Benjamin, Anthony S. Stein

Therapeutic Advances in Hematology

Select article: Selinexor for the treatment of patients with relapsed or refractory multiple myeloma

Retricted access

Review article

First published 2024-4

Selinexor for the treatment of patients with relapsed or refractory multiple myeloma

Anum Babar, Maham Babar, Hina Zubair [...]

Journal of Oncology Pharmacy Practice

Select article: The effect of gemcitabine,dexamethasone,and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience

Retricted access

Research article

First published 2020-12

The effect of gemcitabine,dexamethasone,and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience

Hikmettullah Batgi, Alparslan Merdin, Mehmet Sinan Dal [...]

Journal of Oncology Pharmacy Practice

Select article: The role of belantamab mafodotin for patients with relapsed and/or refractory multiple myeloma

Open access

Review article

First published 2020

The role of belantamab mafodotin for patients with relapsed and/or refractory multiple myeloma

Melody R. Becnel, Hans C. Lee

Therapeutic Advances in Hematology

Select article: A Phase II Study of 131 I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma

Open access

Research article

First published 2023

A Phase II Study of 131 I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma

Yoon Jung Jang, Sang Moo Lim, Inki Lee [...]

Clinical Medicine Insights: Oncology

Select article: Tafasitamab and lenalidomide for relapsed/refractory diffuse large B-cell lymphoma in a patient on chronic intermittent hemodialysis

Retricted access

Case report

First published 2023-1

Tafasitamab and lenalidomide for relapsed/refractory diffuse large B-cell lymphoma in a patient on chronic intermittent hemodialysis

Donald C Moore, Keren A Eagers, Amanda Janes [...]

Journal of Oncology Pharmacy Practice

Select article: From clinical trials to clinical practice: single-agent carfilzomib adverse events and their management in patients with relapsed and/or refractory multiple myeloma

Free access

Review article

First published 2013-12

From clinical trials to clinical practice: single-agent carfilzomib adverse events and their management in patients with relapsed and/or refractory multiple myeloma

David S. Siegel

Therapeutic Advances in Hematology

Select article: Thalidomide Dosing in Patients with Relapsed or Refractory Multiple Myeloma

Retricted access

Research article

First published 2003-4

Thalidomide Dosing in Patients with Relapsed or Refractory Multiple Myeloma

Jennifer L Thompson, Lea Ann Hansen

Annals of Pharmacotherapy

Select article: Safety and efficacy of pralatrexate in the treatment of patients with relapsed or refractory peripheral T-cell lymphoma

Free access

Research article

First published 2012-8

Safety and efficacy of pralatrexate in the treatment of patients with relapsed or refractory peripheral T-cell lymphoma

Enrica Marchi, Owen A. O’Connor

Therapeutic Advances in Hematology

Select article: Successful reintroduction of blinatumomab in a patient with relapsed/refractory acute lymphoblastic leukemia following grade 4 cytokine release syndrome

Retricted access

Case report

First published 2018-1

Successful reintroduction of blinatumomab in a patient with relapsed/refractory acute lymphoblastic leukemia following grade 4 cytokine release syndrome

Bernard L Marini, Yihan Sun, Patrick W Burke [...]

Journal of Oncology Pharmacy Practice

1
2
3
•••
56
10 / page

Article type

Publication date

Subjects

Access